Unison Asset Management LLC Has $9.43 Million Stake in Elevance Health, Inc. (NYSE:ELV)

Unison Asset Management LLC increased its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 6.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 25,557 shares of the company’s stock after purchasing an additional 1,526 shares during the quarter. Elevance Health accounts for approximately 4.6% of Unison Asset Management LLC’s portfolio, making the stock its 8th largest position. Unison Asset Management LLC’s holdings in Elevance Health were worth $9,428,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Raelipskie Partnership bought a new position in shares of Elevance Health in the third quarter worth approximately $26,000. PSI Advisors LLC purchased a new position in shares of Elevance Health in the third quarter valued at about $27,000. Eastern Bank purchased a new stake in Elevance Health in the 3rd quarter worth approximately $31,000. Crews Bank & Trust bought a new stake in Elevance Health in the fourth quarter valued at $34,000. Finally, Dunhill Financial LLC boosted its stake in shares of Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

Elevance Health Stock Up 0.2 %

Shares of Elevance Health stock opened at $391.23 on Friday. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26. The company has a market cap of $90.73 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 1.19 and a beta of 0.83. The company’s 50 day moving average is $386.20 and its 200 day moving average is $454.49.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. Research analysts anticipate that Elevance Health, Inc. will post 34.07 EPS for the current year.

Elevance Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be given a dividend of $1.71 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 annualized dividend and a dividend yield of 1.75%. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s dividend payout ratio is presently 25.46%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Argus reaffirmed a “hold” rating and issued a $405.40 target price on shares of Elevance Health in a research report on Wednesday, January 29th. Stephens cut shares of Elevance Health from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $520.00 to $440.00 in a report on Wednesday, January 22nd. Raymond James set a $485.00 target price on shares of Elevance Health in a report on Friday, October 18th. Royal Bank of Canada reduced their price objective on Elevance Health from $585.00 to $478.00 and set an “outperform” rating for the company in a research report on Friday, October 18th. Finally, Barclays boosted their target price on Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.